FDA Inspection 694616 — Carter BloodCare at Lockheed

Carter BloodCare at Lockheed — FEI 3002965640

The FDA completed an inspection of Carter BloodCare at Lockheed on October 9, 2010 in White Settlement, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 9, 2010
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
White Settlement, TX (United States)